Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children DM Rabi, KA McBrien, R Sapir-Pichhadze, M Nakhla, SB Ahmed, ... Canadian Journal of Cardiology 36 (5), 596-624, 2020 | 519 | 2020 |
MEN4 and CDKN1B mutations: the latest of the MEN syndromes R Alrezk, F Hannah-Shmouni, CA Stratakis Endocrine-related cancer 24 (10), T195-T208, 2017 | 179 | 2017 |
Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians F Hannah-Shmouni, R Morissette, N Sinaii, M Elman, TR Prezant, ... Genetics in Medicine 19 (11), 1276-1279, 2017 | 127 | 2017 |
Genetics of hypertension in African Americans and others of African descent M Zilbermint, F Hannah-Shmouni, CA Stratakis International journal of molecular sciences 20 (5), 1081, 2019 | 90 | 2019 |
Genetics of congenital adrenal hyperplasia F Hannah-Shmouni, W Chen, DP Merke Endocrinology and Metabolism Clinics 46 (2), 435-458, 2017 | 89 | 2017 |
Prevalence of diabetes and hypertension and their associated risks for poor outcomes in Covid-19 patients FJ Barrera, S Shekhar, R Wurth, PJ Moreno-Pena, OJ Ponce, ... Journal of the Endocrine Society 4 (9), bvaa102, 2020 | 83 | 2020 |
Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation S Gubbi, F Hannah-Shmouni, JG Verbalis, CA Koch Best Practice & Research Clinical Endocrinology & Metabolism 33 (6), 101371, 2019 | 83 | 2019 |
Application of whole exome sequencing in the clinical diagnosis and management of inherited cardiovascular diseases in adults SB Seidelmann, E Smith, L Subrahmanyan, D Dykas, MD Abou Ziki, ... Circulation: Cardiovascular Genetics 10 (1), e001573, 2017 | 70 | 2017 |
Genetics of gigantism and acromegaly F Hannah-Shmouni, G Trivellin, CA Stratakis Growth hormone & IGF research 30, 37-41, 2016 | 67 | 2016 |
Flushing in (neuro) endocrinology F Hannah-Shmouni, CA Stratakis, CA Koch Reviews in Endocrine and Metabolic Disorders 17, 373-380, 2016 | 66 | 2016 |
Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions S Gubbi, F Hannah-Shmouni, CA Stratakis, CA Koch Reviews in Endocrine and Metabolic Disorders 19, 335-347, 2018 | 50 | 2018 |
Adrenocortical tumorigenesis: Lessons from genetics CDC Kamilaris, F Hannah-Shmouni, CA Stratakis Best Practice & Research Clinical Endocrinology & Metabolism 34 (3), 101428, 2020 | 48 | 2020 |
Artificial intelligence and machine learning in endocrinology and metabolism: the dawn of a new era S Gubbi, P Hamet, J Tremblay, CA Koch, F Hannah-Shmouni Frontiers in endocrinology 10, 185, 2019 | 44 | 2019 |
Endocrine conditions and COVID-19 S Shekhar, R Wurth, CDC Kamilaris, G Eisenhofer, FJ Barrera, ... Hormone and Metabolic Research 52 (07), 471-484, 2020 | 43 | 2020 |
Hookah smoking and COVID-19: call for action S Shekhar, F Hannah-Shmouni Cmaj 192 (17), E462-E462, 2020 | 41 | 2020 |
Diagnostic testing for diabetes insipidus S Gubbi, F Hannah-Shmouni, CA Koch, JG Verbalis | 40 | 2019 |
Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes RO Yeung, F Hannah-Shmouni, K Niederhoffer, MA Walker Reviews in Endocrine and Metabolic Disorders 19, 35-52, 2018 | 39 | 2018 |
Recurrent exercise-induced rhabdomyolysis F Hannah-Shmouni, K McLeod, S Sirrs Cmaj 184 (4), 426-430, 2012 | 33 | 2012 |
Neurological manifestations of Erdheim–Chester disease LC Boyd, KJ O’Brien, N Ozkaya, T Lehky, A Meoded, BR Gochuico, ... Annals of clinical and translational neurology 7 (4), 497-506, 2020 | 30 | 2020 |
Management of mitochondrial diabetes in the era of novel therapies RO Yeung, M Al Jundi, S Gubbi, ME Bompu, S Sirrs, M Tarnopolsky, ... Journal of Diabetes and its Complications 35 (1), 107584, 2021 | 29 | 2021 |